Drug Shortage Report for MIFEGYMISO
| Report ID | 175501 |
| Drug Identification Number | 02444038 |
| Brand name | MIFEGYMISO |
| Common or Proper name | Mifepristone/Misoprostol |
| Company Name | LINEPHARMA INTERNATIONAL LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MISOPROSTOL MIFEPRISTONE |
| Strength(s) | 200MCG 200MG |
| Dosage form(s) | TABLET KIT |
| Route of administration | ORAL BUCCAL ORAL BUCCAL |
| Packaging size | Combipack - 1 box with 1 tablet of mifepristone 200mg tablet + 1 box with 4 tablets of 200mcg misoprostol |
| ATC code | G03XB |
| ATC description | OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-11-23 |
| Actual start date | 2022-11-23 |
| Estimated end date | 2022-12-20 |
| Actual end date | 2022-12-20 |
| Shortage status | Resolved |
| Updated date | 2022-12-21 |
| Company comments | Mifegymiso(R) is available on 2022-DEC-20 at Linepharma International Inc. Wholesaler. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16 UPPER WOBURN PLACE LONDON, GREATER LONDON UNITED KINGDOM WC1H0BS |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.